Home / Media Center / News

Search

SEVENTH ANNUAL TGaS ADVISORS BEST OF BENCHMARK AWARD WINNERS ANNOUNCED

AbbVie, Astellas Pharma Inc., AstraZeneca, Incyte, Eli Lilly and Company and Novo Nordisk Teams Take Home Trophies for Operational Excellence Waltham, MA, May 29, 2024 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the winners of the TGaS Advisors Best of Benchmark (BoBs) Awards. The Awards, which are given annually for operational excellence within the pharmaceutical industry, were presented to teams at AbbVie, Astellas Pharma Inc., AstraZeneca, Incyte, Eli Lilly and Company and Novo Nordisk.…

Read Now

TRINITY LIFE SCIENCES LAUNCHES THE ONLY PREDICTIVE INSIGHTS SOLUTION POWERED BY AIML AND GROUNDED IN MARKET RESEARCH AND REAL-WORLD DATA

Trinity Real Insights is Now Available Waltham, MA, May 1, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched a new solution that accurately predicts stakeholder behavior providing deeper insights. For the first time, life sciences companies can incorporate real-world, healthcare professional (HCP)-specific prescribing behaviors with primary market research (PMR). This integration provides a view of what physicians are currently doing that is independent of what those physicians may say in market research studies.…

Read Now

TRINITY LIFE SCIENCES UNVEILS INDUSTRY IMPACT SERIES TO SUPPORT LIFE SCIENCES EXECUTIVES ON CRITICAL DECISION MAKING

“Picking Winners: Portfolio Management for a New Era” White Paper Now Available Waltham, MA, April 3, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, unveils its Industry Impact Series—a thought leadership series designed to identify key issues that will revolutionize the way therapeutics are developed and commercialized in the years ahead. The first installment of the series, a white paper entitled Picking Winners: Portfolio Management for a New Era, explores the challenges biopharma companies face in selecting…

Read Now

TRINITY LIFE SCIENCES REVEALS SIX KEY GLOBAL MARKET ACCESS TRENDS THAT LIFE SCIENCES COMPANIES NEED TO BE MONITORING

“Annual State of Global Market Access” White Paper Now Available An Upcoming Webinar Entitled “Annual State of Global Market Access” Will Review Findings Waltham, MA, March 26, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Annual State of Global Market Access white paper, an evaluation of six key global market access trends that life sciences companies need to be monitoring in 2024 and beyond. The paper explores the consequences of new therapeutic…

Read Now

TRINITY LIFE SCIENCES LAUNCHES BRAND INSIGHTS AI

New Chat-based AI Interface Allows Life Sciences Executives to Unlock the Collective Power of All Their Brand Research Waltham, MA, February 28, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research. Designed by experts with deep technical knowledge and expertise in the nuances of life sciences research, it allows insights and analytics teams to answer brand questions…

Read Now

TRINITY LIFE SCIENCES EVALUATES COMMERCIAL PERFORMANCE OVER 3 YEARS OF 58 NOVEL DRUGS APPROVED IN 2020

“Trinity Annual Drug Index” White Paper Now Available An Upcoming Webinar Entitled “Learn From the Past – Launch Better Tomorrow” Will Review Findings Waltham, MA, February 13, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Trinity Annual Drug Index white paper, an evaluation of the commercial performances over three years of 58 novel drugs approved in 2020. An upcoming webinar Learn From the Past – Launch Better Tomorrow will help…

Read Now

CHINA’S 2022 NRDL UPDATE DEMONSTRATES PROMISING PRICING AND ACCESS OPPORTUNITIES FOR INNOVATIVE DRUGS WITH SIGNIFICANT CLINICAL BENEFIT

New White Paper “2022 NRDL Pricing Implementation and Access Outcomes in China” Available Now from Trinity Life Sciences Waltham, MA, December 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that China’s 2022 National Reimbursement Drug List (NRDL) demonstrates promising pricing and access opportunities for innovative drugs with significant clinical benefit. The new white paper “2022 NRDL Pricing Implementation and Access Outcomes in China” provides an in-depth analysis and key takeaways of the update.…

Read Now

TRINITY LIFE SCIENCES INSTITUTES A FORMAL CELL AND GENE THERAPY CENTER OF EXCELLENCE

COE Provides Deep Strategic Expertise and Analytical Capabilities to Support Cell and Gene Therapy Organizations Across the Value Chain New White Paper “Empowering Cancer Immunotherapy: Unleashing the Potential of NK Cell Therapies in Oncology” Delivers Overarching Assessment of the Natural Killer Cell Therapy Space Waltham, MA, December 18, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces a Cell & Gene Therapy (C&GT) Center of Excellence (COE) that supports life sciences companies in successfully commercializing…

Read Now

NEW ADVISORY BRIEF REVEALS WHAT LIFE SCIENCES COMPANIES NEED TO KNOW NOW TO BE PREPARED FOR 2024

Waltham, MA, December 13, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know Now To Be Prepared for 2024” based on highlights presented at the TGaS Advisors’ 2023 Fall Client Summit. The TGaS 2023 Fall Client Summit included 16 function-specific sessions in the areas of commercial operations, market access and medical affairs. The sessions were held virtually in October and November with over 500…

Read Now

PFIZER’S NURTEC RECEIVES TOP RANKING IN 2023 TGAS DIGITAL MARKETING COMPETENCY REPORT

Waltham, MA, November 29, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a brand digital competency ranking. Brands that topped the 2023 Digital Marketing Competency Report’s list include: Pfizer’s Nurtec Idorsia’s Quviviq…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.